CB2R agonist prevents nicotine induced lung fibrosis. (9th August 2018)
- Record Type:
- Journal Article
- Title:
- CB2R agonist prevents nicotine induced lung fibrosis. (9th August 2018)
- Main Title:
- CB2R agonist prevents nicotine induced lung fibrosis
- Authors:
- Wawryk-Gawda, Ewelina
Chłapek, Katarzyna
Zarobkiewicz, Michał K.
Lis-Sochocka, Marta
Chylińska-Wrzos, Patrycja
Boguszewska-Czubara, Anna
Sławiński, Mirosław A.
Franczak, Anna
Jodłowska-Jędrych, Barbara
Biała, Grażyna - Abstract:
- Abstract: Introduction : Nicotine stimulates fibroblast proliferation while increasing inflammation and fibrosis of tissues. The cannabinoid receptor 1 (CB1R) is mainly located in the CNS, while cannabinoid receptor 2 (CB2R) is located in the immune cells within the body. CB2R regulates inflammatory processes and fibroblast function.Purpose: We investigated the impact of CB2R agonist, JWH 133 and the antagonist, AM630 on lung tissue, applied directly before nicotine application.Material and methods: 40 mice were placed into 4 groups. The experimental groups received nicotine intraperitoneally at a dose of 0.05 mg/kg of body weight (BW) for 14 days. Group B also received AM630 (0.5mg/kg of BW), while Group A was administered with JWH133 (1 mg/kg of BW). Group N received nicotine alone. The Control group C received 0.9% NaCl. After decapitation, lung tissues were stained with H&E, Trichrome Masson's method, and IHC against CTGF and α-SMA. The digital image processing system Image J with the IHC profiler plugins was then employed, optical density and IHC optical density score were calculated.Results: In the N group, an increase in the thickness of alveolar spaces (9.16 SD4.95µm vs. 4.77SD2.99µm in the C group), leukocytes infiltration and collagen deposition has been observed(OD: 0.20 SD0.0vs 0.07SD0.04 in the C group). In the B group, the alveolar space thickness has been the highest (11.57SD8.13µm). Furthermore, in this group, hyperaemia, destruction of lung structure,Abstract: Introduction : Nicotine stimulates fibroblast proliferation while increasing inflammation and fibrosis of tissues. The cannabinoid receptor 1 (CB1R) is mainly located in the CNS, while cannabinoid receptor 2 (CB2R) is located in the immune cells within the body. CB2R regulates inflammatory processes and fibroblast function.Purpose: We investigated the impact of CB2R agonist, JWH 133 and the antagonist, AM630 on lung tissue, applied directly before nicotine application.Material and methods: 40 mice were placed into 4 groups. The experimental groups received nicotine intraperitoneally at a dose of 0.05 mg/kg of body weight (BW) for 14 days. Group B also received AM630 (0.5mg/kg of BW), while Group A was administered with JWH133 (1 mg/kg of BW). Group N received nicotine alone. The Control group C received 0.9% NaCl. After decapitation, lung tissues were stained with H&E, Trichrome Masson's method, and IHC against CTGF and α-SMA. The digital image processing system Image J with the IHC profiler plugins was then employed, optical density and IHC optical density score were calculated.Results: In the N group, an increase in the thickness of alveolar spaces (9.16 SD4.95µm vs. 4.77SD2.99µm in the C group), leukocytes infiltration and collagen deposition has been observed(OD: 0.20 SD0.0vs 0.07SD0.04 in the C group). In the B group, the alveolar space thickness has been the highest (11.57SD8.13µm). Furthermore, in this group, hyperaemia, destruction of lung structure, hyperplasia of II type pneumocyte and interstitial fibrosis has been observed (OD: 0.23 SD0.08). In contrast, the lung tissue of the A group has had normal structure and the thinnest alveolar septum (3.88 SD2.64µm). The expression of CTGF and α-SMA has been the highest in the B group.Conclusion : Nicotine induces interstitial lung fibrosis that is enhanced by the CB2R antagonist and diminished by the CB2R agonist. Therefore, the CB2R agonist may offer a protection against fibrosis. … (more)
- Is Part Of:
- Experimental lung research. Volume 44:Number 7(2018)
- Journal:
- Experimental lung research
- Issue:
- Volume 44:Number 7(2018)
- Issue Display:
- Volume 44, Issue 7 (2018)
- Year:
- 2018
- Volume:
- 44
- Issue:
- 7
- Issue Sort Value:
- 2018-0044-0007-0000
- Page Start:
- 344
- Page End:
- 351
- Publication Date:
- 2018-08-09
- Subjects:
- fibrosis -- cannabinoids -- lung -- nicotine
Lungs -- Periodicals
Lungs -- Diseases -- Periodicals
Lung Diseases
Lung -- physiology
Respiratory System
616.24 - Journal URLs:
- http://informahealthcare.com/loi/elu ↗
http://www.tandfonline.com/loi/ielu20 ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/01902148.2018.1543368 ↗
- Languages:
- English
- ISSNs:
- 0190-2148
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3839.440000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 9524.xml